What are the side effects of brigatinib/brigatinib?
Brigatinib is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer in a U.S. Food and Drug Administration (FDA)-approved test.

Brigatinib/Brigatinib(Brigatinib)What are the side effects?
Brigatinib/Common side effects of brigatinib includeincreased transaminases (38%) and hyperglycemia (38%), Elevated alanine aminotransferase (34%), Nausea (33%), Fatigue (29%), Headache (28%), CPKIncrease (27%), Amylase increase (27%), Difficulty breathing (27%), Vomiting (24%), Anemia (23%), Decreased appetite (22%), aPTTprolongation (22%), increased lipase (21%), diarrhea (< /span>19%), Constipation (19%), Lymphopenia (19%), Cough (18%
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)